Meeting the Institute of Medicine's 2030 US Life Expectancy Target.
Where this comes from
- Record sourced from PubMed, PMID 29161064.
- Also identified by DOI 10.2105/AJPH.2017.304099 and PMC identifier 5719677.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To quantify the improvement in US life expectancy required to reach parity with high-resource nations by 2030, to document historical precedent of this rate, and to discuss the plausibility of achieving this rate in the United States. We performed a demographic analysis of secondary data in 5-year periods from 1985 to 2015. To achieve the United Nations projected mortality estimates for Western Europe in 2030, the US life expectancy must grow at 0.32% a year between 2016 and 2030. This rate has precedent, even in low-mortality populations. Over 204 country-periods examined, nearly half exhibited life-expectancy growth greater than 0.32%. Of the 51 US states observed, 8.2% of state-periods demonstrated life-expectancy growth that exceeded the 0.32% target. Achieving necessary growth in life expectancy over the next 15 years despite historical precedent will be challenging. Much all-cause mortality is structured decades earlier and, at present, older-age mortality reductions in the United States are decelerating. Addressing mortality decline at all ages will require enhanced political will and a strong commitment to equity improvement in the US population.
Medical subject headings
- Demography
- Life Expectancy
- National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division